Hydroxocobalamin
Injection · trading as Cyanokit
Current
FDA shortage record
- Substance
- Hydroxocobalamin
- Brand name
- Cyanokit
- Manufacturer
- BTG INTERNATIONAL INC.
- Dosage form
- Injection
- Presentation
- Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)
- Route(s)
- INTRAVENOUS
- Therapeutic category
- Other
- Package NDC
50633-310-11- Initially posted
- 11/04/2024
- Current FDA status
- Current
Reason and context
Reason reported: Requirements related to complying with good manufacturing practices
Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.
Manufacturer contact
Per the FDA record, the manufacturer's contact for supply inquiries is 844-293-0007.
If you're affected by this shortage
- Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
- Ask your pharmacy to check supply across multiple wholesalers and other branches.
- Check current pharmacy pricing and availability via GoodRx (affiliate link).
- Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.
Sources
- FDA Drug Shortages database, accessed via the openFDA Drug Shortages API.
- FDA Structured Product Label (SPL set ID
d56fcc8d-bd64-46ab-b0c0-2124bd745a6b). - FDA UNII identifier:
Q40X8H422O. - See the Drug Shortage Tracker methodology for sourcing, update cadence, normalization rules, and limits.
Important
This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.